Metropolis Healthcare Reports Positive Q4 Results, Strong Financial Performance Indicated

May 21 2024 09:15 PM IST
share
Share Via
Metropolis Healthcare, a leading healthcare services company, has reported positive financial results for the quarter ending March 2024. The company's strong performance is attributed to its effective management of interest payments, highest quarterly net sales in five quarters, and significant growth in key financial indicators such as Operating Profit and Profit Before Tax.
Metropolis Healthcare, a leading healthcare services company in the midcap industry, has recently announced its financial results for the quarter ending March 2024. The company has shown a positive performance in this quarter, with a significant improvement in its overall score from -10 to 8 in the last three months.

One of the key factors contributing to this positive performance is the company's ability to manage its interest payments, with an impressive Operating Profit to Interest ratio of 14.36 times in the last five quarters. This indicates that Metropolis Healthcare is effectively managing its financial obligations and is on a path towards financial stability.

In terms of sales, the company has achieved its highest quarterly net sales of Rs 331.00 crore in the last five quarters, indicating a positive trend in its sales performance. Additionally, the company's Operating Profit (PBDIT) has also shown a positive trend, with its highest quarterly value of Rs 79.98 crore in the last five quarters.

Moreover, Metropolis Healthcare has also seen a significant growth in its Profit Before Tax less Other Income (PBT) for the quarter, with a highest value of Rs 47.99 crore. This is a 21.3% increase over the average PBT of the previous four quarters, showcasing the company's strong financial performance.

Furthermore, the company's Profit After Tax (PAT) has also shown a positive trend, with its highest quarterly value of Rs 36.41 crore in the last five quarters. This indicates that Metropolis Healthcare is not only increasing its profitability, but also creating higher earnings for its shareholders, as reflected in its highest quarterly Earnings per Share (EPS) of Rs 7.10.

Overall, Metropolis Healthcare has shown a strong financial performance in the quarter ending March 2024, with positive trends in key financial indicators. This has led to a 'Buy' call for the company's stock by MarketsMOJO, making it a promising investment opportunity in the midcap healthcare industry.
{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News